New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 27, 2014
12:50 EDTMET, GAME, NKTR, SVU, PHHHigh option volume stocks: PHH NKTR MET SVU GAME
News For PHH;NKTR;MET;SVU;GAME From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
December 12, 2014
08:09 EDTMETBofA/Merrill financial analysts hold an analyst/industry conference call
Banks Analyst Najarian, along with Capital Markets Analyst Carrier, Specialty Finance Analyst Bruce discuss the year ahead in Financials, covering the Banks, Capital Markets, Life and P/C Insurance, REIT, Specialty Finance and Canadian Banks/Life Insurance sectors on an Analyst/Industry conference call to be held on December 16 at 10 am.
06:34 EDTMETMetLife announces new $1B share repurchase authorization
Subscribe for More Information
December 11, 2014
18:03 EDTNKTRNektar reports data from Phase 3 BEACON study of NKTR-102
Nektar Therapeutics presented biomarker data from a sub-study of the Phase 3 BEACON study of etirinotecan pegol (NKTR-102) which collected and analyzed circulating tumor cell samples from patients in the study. A total of 80% of the 852 patients enrolled in the BEACON trial participated in the CTC sub-study. Among the 627 patients who participated and had evaluable baseline samples, CTCs were detected in 97% of these samples. For the 611 evaluable baseline patient samples which yielded CTCs, potential NKTR-102 target-specific pharmacodynamic biomarkers were detected in the majority of samples. The pharmacodynamic biomarkers assessed in the CTC sub-study were chosen because of their potential ability to predict response to topoisomerase inhibition as well as to measure chemo-sensitivity in metastatic cancer patients
11:17 EDTMETMetLife to host investor conference call
Investor Conference Call to be held on December 12 at 8 am. Reference Link
08:30 EDTMETMetLife acquires Fairmont Hotel in Washington, D.C. for $180M
Subscribe for More Information
08:05 EDTNKTRFDA Pediatric Oncologic Subcommittee to hold a meeting
Subscribe for More Information
December 10, 2014
18:38 EDTMETMetLife statement on passage of Insurance Capital Standards Clarification Act
Subscribe for More Information
14:01 EDTMETMetLife names Esther Lee Global Chief Marketing Officer
Subscribe for More Information
13:51 EDTPHHT. Rowe Price reports 11.2% passive stake in PHH Corp.
10:10 EDTPHHHigh option volume stocks
Subscribe for More Information
December 9, 2014
10:23 EDTSVUOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
08:02 EDTNKTRMoventig approved in EU for opioid-induced constipation
Nektar (NKTR) reported partner AstraZeneca (AZN) announced that MOVENTIG has been granted Marketing Authorisation by the European Commission for the treatment of opioid-induced constipation in adult patients who have had an inadequate response to laxative. MOVENTIG is the first once-daily oral peripherally-acting mu-opioid receptor antagonist to be approved in the European Union.
07:44 EDTNKTRAmerican Association for Cancer Research to hold a symposium
Subscribe for More Information
06:23 EDTSVUSupervalu downgraded after share outperformance at Oppenheimer
Subscribe for More Information
06:02 EDTMETMetLife affiliates and other investor provide $200M in financing to Angel Trains
Subscribe for More Information
05:54 EDTSVUSupervalu downgraded to Perform from Outperform at Oppenheimer
Subscribe for More Information
December 8, 2014
10:17 EDTGAMEShanda Games informed of new consortium to acquire company
Shanda Games has been informed that Yili Shengda Investment and certain of Yili's affiliates filed a statement on Schedule 13D with respect to Shanda Games on December 5, 2014. According to the 13D Statement, Ningxia Yilida Capital Investment and Ningxia Zhongyincashmere International Group entered into a consortium agreement on December 5, 2014 pursuant to which they have agreed to form a consortium to acquire the company in a "going private" transaction. As previously announced, the board of the company received a preliminary non-binding proposal letter dated January 27, 2014 from a consortium then consisting of Shanda Interactive Entertainment Limited and certain other parties. According to the SNDA Proposal, the SNDA Consortium proposed to acquire the company in a "going private" transaction for $3.45 per Class A Share or Class B Share, or $6.90 per ADS. The Special Committee has not set a definitive timetable for the completion of its evaluation of the Proposed Transaction or any other alternative transaction and does not currently intend to announce developments unless and until an agreement has been reached. The company cautions its shareholders and others considering trading its securities that there can be no assurance that any definitive agreement will be executed relating to the Proposed Transaction, or that the Proposed Transaction or any other transaction will be approved or consummated.
07:29 EDTNKTRUBS to hold investor trip
Subscribe for More Information
07:18 EDTNKTRUBS to hold investor trip
2014 Annual West Coast Investor Trip travels on the West Coast on December 8-10.
December 4, 2014
18:20 EDTMETMetLife close to systemically important label, Bloomberg reports
Subscribe for More Information
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use